August 2018 - Volume 38 - Issue 4

  • Richard I. Shader, MD
    David J. Greenblatt, MD
  • 0271-0749
  • 1533-712X
  • 6 issues / year
  • Psychiatry 21/142; Pharmacy and Pharmacology 22/261
  • 3.134

Hybrid Open Access

As all of you know, many innovations are taking place in journal publishing, especially now that we appear to be approaching a total digital age. Our publisher, Wolters Kluwer | Lippincott Williams & Wilkins, has responded to this and to a growing interest in open access (OA) and the increasing number of requirements from funding bodies and institutions for public availability of the work by implementing an article-level open access option for many of its journals. Commonly known as "Hybrid Open Option (HOA)", JCP will continue to be sold on a subscription basis, but authors may opt to make their articles freely available online immediately upon publication by paying an Article Processing Charge (APC). Any additional standard publication charges for print, such as for color images, may also apply.

Our instructions to authors is updated to facilitate this change.

Richard I. Shader, M.D.

David J. Greenblatt, M.D.

Current Issue Highlights

The Prescription of Benzodiazepines for Panic Disorder: Time for an Evidence-Based Educational Approach

Nardi, Antonio E.; Cosci, Fiammetta; Balon, Richard; More

Journal of Clinical Psychopharmacology. 38(4):283-285, August 2018.

Neurocognitive Effects of Agomelatine Treatment in Schizophrenia Patients Suffering From Comorbid Depression: Results From the AGOPSYCH Study

Englisch, Susanne; Jung, Hanna Sophie; Eisenacher, Sarah; More

Journal of Clinical Psychopharmacology. 38(4):357-361, August 2018.